THE NEPHROPATHY OF GOUT
Authors: S K FINEBERG, A ALTSCHUL
Journal: Annals of Internal Medicine (1956)

Article1 June 1956THE NEPHROPATHY OF GOUTS. K. FINEBERG, M.D., F.A.C.P., A. ALTSCHUL, M.D., F.A.C.P.S. K. FINEBERG, M.D., F.A.C.P., A. ALTSCHUL, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-44-6-1182 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptGout may be succinctly defined as a disorder of purine metabolism characterized by hyperuricemia and a typical form of recurrent acute arthritis which often eventually is associated with urate deposits in cartilages, bone, joint spaces, bursae, tendons,kidneysand other tissues.1Although the existence of a "gouty nephritis" as a "complication" of this disease has long been recognized,2, 3, 4, 5the high incidence of renal damage and its true place as an integral part of the whole disease process do not appear to be generally appreciated. Careful study, however, reveals that the metabolic error in gout produces not only...Bibliography1. Gutman AB: Some recent advances in the study of uric acid metabolism and gout, Bull. New York Acad. Med. 27: 144 (Mar.) 1951. MedlineGoogle Scholar2. Bell ET: Renal diseases, 2nd Ed., 1950, Lea and Febiger, Philadelphia, p. 413. Google Scholar3. Talbott JH: Gout, in Oxford system of medicine, 1949, Oxford University Press, New York, 1949, p. 125. Google Scholar4. McCabe ES: Gout—recent advances, Bull. School Med. Univ. Maryland 36: 126 (July) 1951. MedlineGoogle Scholar5. McQueen EG: The syndrome of gout, M. J. Australia 38: 644 (May 5) 1951. CrossrefGoogle Scholar6. Gudzent F: Gicht und Rheumatismus, 1928, Springer, Berlin. CrossrefGoogle Scholar7. BrownMallory JGK: Renal changes in gout, New England J. Med. 243: 325 (Aug. 31) 1950. CrossrefMedlineGoogle Scholar8. TalbottLockie JHLM: Gouty arthritis, Ciba Clinical Symposia 2: 319 (Dec.) 1950. Google Scholar9. Talbott JH: The diversity of gouty arthritis and its complications, Ann. Int. Med. 31: 555 (Oct.) 1949. LinkGoogle Scholar10. Oehlecker F: Beziehungen zwischen Gicht und Niere, Chirurg. 22: 1 (Jan.) 1951. MedlineGoogle Scholar11. Bramigk F: Impressions of gout, J. Michigan M. Soc. 49: 1297 (Nov.) 1950. MedlineGoogle Scholar12. Smyth CJ: The genetic aspects of rheumatic diseases, Bull. Rheumat. Dis. (Arthritis and Rheumatism Foundation) 2: 7 (Dec.) 1951. MedlineGoogle Scholar13. ThornEmerson GWK: Gout, in Principles of internal medicine, edited by T. R. Harrison, 1951, The Blakiston Co., Philadelphia, p. 697. Google Scholar14. BenedictRocheYüBienGutmanStetten JDMTFEJABD: Incorporation of glycine nitrogen into uric acid in normal and gouty man, Metabolism 1: 3 (Jan.) 1952. MedlineGoogle Scholar15. FriedmanByers MSO: Increased renal excretion of urate in young patients with gout, Am. J. Med. 9: 31 (July) 1950. CrossrefMedlineGoogle Scholar16. Stetten D: The metabolic defect in gout, Bull. Rheumat. Dis. (Arthritis and Rheumatism Foundation) 3: 25 (Dec.) 1952. MedlineGoogle Scholar17. Hoffman WS: Metabolism of uric acid and its relation to gout, J. A. M. A. 154: 213 (Jan. 16) 1954. CrossrefMedlineGoogle Scholar18. Talbott JH: Clinical and metabolic effects of Benemid in gout, Bull. Rheumat. Dis. (Arthritis and Rheumatism Foundation) 2: 1 (Sept.) 1951. MedlineGoogle Scholar19. HessRothKaminsky ERBAF: Staghorn calculi, J. Urol. 69: 347 (Mar.) 1953. CrossrefMedlineGoogle Scholar20. SpitzSteinbrockerSchwartzSchittone HOSM: Fulminating fatal gout, Am. J. Med. 6: 513 (Apr.) 1949. CrossrefMedlineGoogle Scholar21. GerenBendichBodanskyBrown WAOGB: The fate of uric acid in man, J. Biol. Chem. 183: 21 (Mar.) 1950. CrossrefGoogle Scholar22. BishopGarnerTalbott CWJH: Pool size, turnover rate and rapidity of equilibrium of injected isotopic uric acid in normal and pathological subjects, J. Clin. Investigation 30: 879 (Aug.) 1951. CrossrefMedlineGoogle Scholar23. SirotaYüGutman JHTFAB: Effect of Benemid (p-(di-n-propylsulfamyl)-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects, J. Clin. Investigation 31: 692 (July) 1952. CrossrefMedlineGoogle Scholar24. PascaleDubinHoffman LRAWS: Therapeutic value of probenecid (Benemid) in gout, J. A. M. A. 149: 1188 (July 26) 1952. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication February 13, 1956.From the Metabolic Service of The Harlem Hospital, New York, N. Y.Requests for reprints should be addressed to S. K. Fineberg, M.D., 1056 Fifth Avenue, New York 28, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe anatomical pathology of gout: a systematic literature reviewUric Acid CalculiDie pathologische Anatomie der GichtRenal function abnormalities in patients with asymptomatic hyperuricemiaRenal disease in primary gout: A study of 253 gout patients with proteinuriaUrate Deposition Disease How Is It Regulated and How Can It Be Modified?JAMES R. KLINENBERG, M.D., F.A.C.P., RODNEY BLUESTONE, M.B., M.R.C.P., LEE SCHLOSSTEIN, M.D., JERRY WAISMAN, M.D., MICHAEL W. WHITEHOUSE, D. Phil.La Terapia Medica Della Calcolosi Urica UrinariaPrevention of Hyperuricemia by Allopurinol in Hypertensive Patients Treated with ChlorothiazideUricemia and UrolithiasisPyelonephritis und chronische interstitielle NephritisUric Acid, Gout, and the KidneyThe Renal Lesion in GoutHARVEY C. GONICK, M.D., MILTON E. RUBINI, M.D., IRENE O. GLEASON, M.D., SHELDON C. SOMMERS, M.D.GoutRenal complications of neoplastic diseaseGOUT AND PREGNANCYRHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (THIRTEENTH RHEUMATISM REVIEW)*CHARLEY J. SMYTH, M.D., F.A.C.P., ROGER L. BLACK, M.D., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P.(C), MAX M. MONTGOMERY, M.D., F.A.C.P., HOWARD F. POLLEY, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P., CARLOS F. SACASA, M.D., F.A.C.P., OTTO STEINBROCKER, M.D., HANS WAINE, M.D., GEORGE M. WILSON JR., M.D.HYPERURICÆMIC KIDNEY DISEASERHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (TWELFTH RHEUMATISM REVIEW)* Part IICHARLEY J. SMYTH, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., WILLIAM S. CLARK, M.D., F.A.C.P., DARRELL C. CRAIN, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P. (C), MAX M. MONTGOMERY, M.D., F.A.C.P., BERNARD M. NORCROSS, M.D., F.A.C.P., HOWARD F. POLLEY, MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P.Die Pathomorphologie der Nierenausscheidung 1 June 1956Volume 44, Issue 6Page: 1182-1194KeywordsArthritisGoutMetabolic disordersNephritisPelvisPurine metabolismPyelonephritisRenal diseasesTendonsUric acid ePublished: 1 December 2008 Issue Published: 1 June 1956 PDF downloadLoading ...